LPHYSIO, a South Korean company specializing in premium body care and aesthetic medical devices, has secured approximately $200,000 (KRW 300 million) in a follow-on investment from Star Asset Partners.

The round was executed through Star Asset Partners’ “K-Beauty Star SAP Individual Investment Association No. 1-P” fund, and follows an earlier $66,700 (KRW 100 million) seed investment made in 2025 via the firm’s “K-Food Star SAP-YNA Individual Investment Association No. 1” vehicle. The two rounds together constitute a club deal totaling approximately $266,700 (KRW 400 million).

LPHYSIO’s core product lineup includes the LPG CELLU M6 ALLIANCE, Thermawave, and Thermawave Med — devices designed for body contouring and skin care. The company operates both company-owned centers and franchise locations, using its directly managed sites as test beds to validate equipment performance and service packages while accumulating operational data. It has standardized treatment protocols and operating manuals for distribution to medical institutions and aesthetic clinics, and has expanded into health functional foods and inner beauty products, positioning itself as a total care wellness solutions provider rather than a conventional device distributor.

Star Asset Partners cited the depth of LPHYSIO’s management team as the primary driver of its investment decision. The company is led by co-CEOs who bring complementary expertise: one with over 15 years of hospital administration experience and the other with 16 years in medical device sales and distribution.

“LPHYSIO isn’t just an equipment supplier — it’s a team with an unmatched combination of medical management know-how and distribution expertise,” said Heesung Lee, CEO of Star Asset Partners. “We were impressed by the team’s ability to generate validated data from company-owned centers and standardize it into scalable protocols, and we believe they have what it takes to define new benchmarks in the total wellness market.”